The costs of Psa-V to the New Zealand kiwifruit industry and the wider community

Abstract

This report describes research commissioned by Kiwifruit Vine Health Inc. into the costs imposed by Psa-V, a bacterial disease of kiwifruit, on the New Zealand kiwifruit industry since the disease was first identified in a Te Puke Orchard in November 2010. The research evaluates the impacts of the disease under two potential recovery strategies that have been identified by KVH, in consultation with industry. Industry performance under each of the scenarios has been compared with the expected level of performance under a Status Quo scenario that is based on industry development plans formulated by ZESPRI.